N-chloramines, A promising class of well-tolerated topical anti-infectives

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1107-1114

  Gottardi, Waldemar ^a   Debabov, Dmitri ^b   Nagl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NovaBay Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMINE DERIVATIVE; SODIUM; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BACTERICIDAL ACTIVITY; BIOFILM; CHLORINATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TOLERABILITY; HYDROLYSIS; LIPOPHILICITY; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PH; PRIORITY JOURNAL; PROTON TRANSPORT; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA; CHLORAMINES; CHLORINE COMPOUNDS; FUNGI; HALOGENATION; HUMANS; HYPOCHLOROUS ACID; TAURINE; VIRUSES;

EID: 84874084765     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02132-12     Document Type: Review

References (69)

1. Dychdala GR. 2001. Chlorine and chlorine compounds, p 135-158. In Block SS (ed), Disinfection, sterilization and preservation. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Gottardi W. 2001. Iodine and iodine compounds, p 159-184. In Block SS (ed), Disinfection, sterilization and preservation. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Gottardi W. 1978. On the usability of N-iodo compounds as disinfectants (author's transl). Zentralbl. Bakteriol. B 167:216 -223. (In German.).
4. Gottardi W, Hagleitner M, Nagl M. 2005. N, N-Dichlorotaurine: chemical and bactericidal properties. Arch. Pharm. (Weinheim) 338:473- 483.
5. Low E, Nair S, Shiau T, Belisle B, Debabov D, Celeri C, Zuck M, Najafi R, Georgopapadakou N, Jain R. 2009. N, N-Dichloroaminosulfonic acids as novel topical antimicrobial agents. Bioorg. Med. Chem. Lett. 19:196-198.
6. Labarraque AG, Scott JT. 1828. On the disinfecting properties of Labarraque's preparations of chlorine, p 8. S. Highley, London, England.
7. Semmelweis IP. 1861. Die Ätiologie, der Begriff und die Prophylaxe des Kindbettfiebers. C. A. Hartlebens Verlag, Vienna, Austria.
8. Dakin HD. 1915. On the use of certain antiseptic substances in the treatment of infected wounds. Br. Med. J. 2:318 -320.
9. Dakin HD, Cohen JB. 1916. Studies in antiseptics (II): on chloramine: its preparation, properties, and use. Br. Med. J. 1:160 -162.
10. Smith JL, Drennan AM, Rettie T, Campbell W. 1915. Experimental observations of the antiseptic action of hypochlorous acid and its application to wound treatment. Br. Med. J. 2:129 -136.
11. Selkon JB, Cherry GW, Wilson JM, Hughes MA. 2006. Evaluation of hypochlorous acid washes in the treatment of chronic venous leg ulcers. J. Wound Care 15:33-37.
12. Gstöttner M, Nagl M, Pototschnig C, Neher A. 2003. Refractory rhinosinusitis complicating immunosuppression: application of Nchlorotaurine, a novel endogenous antiseptic agent. ORL J. Otorhinolaryngol. Relat. Spec. 65:303-305.
13. Huber J, Winter P, Gottardi W, Scholl-Bürgi S, Prokop W, Nagl M. 2008. Tolerability of N-chlorotaurine in the in the bovine mammary gland. J. Dairy Res. 75:248 -256.
14. Lorenz K, Mayer D, Bruhn G, Noack B, Brecx M, Heumann C, Toutenburg H, Netuschil L, Nagl M, Gottardi W, Hoffmann T. 2009. Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality. Clin. Oral Investig. 13:9 -14.
15. Nagl M, Pfausler B, Schmutzhard E, Fille M, Gottardi W. 1998. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl. Bakteriol. 288:217-223.
16. Nagl M, Teuchner B, Pöttinger E, Ulmer H, Gottardi W. 2000. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis- a phase II pilot study. Ophthalmologica 214:111-114.
17. Nagl M, Nguyen VA, Gottardi W, Ulmer H, Höpfl R. 2003. Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br. J. Dermatol. 149:590 -597.
18. Neher A, Nagl M, Appenroth E, Gstöttner M, Wischatta M, Reisigl F, Schindler M, Ulmer H, Stephan K. 2004. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 114:850-854.
19. Neher A, Fischer H, Appenroth E, Lass-Floerl C, Mayr A, Gschwendtner A, Ulmer H, Gotwald TF, Gstöttner M, Kozlov V, Nagl M. 2005. Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter. Auris Nasus Larynx 32:359 -364.
20. Neher A, Gstöttner M, Nagl M, Scholtz A, Gunkel AR. 2007. NChlorotaurine- a new safe substance for postoperative ear care. Auris Nasus Larynx 34:19 -22.
21. Teuchner B, Nagl M, Schidlbauer A, Ishiko H, Dragosits E, Ulmer H, Aoki K, Ohno S, Mizuki N, Gottardi W, Larcher C. 2005. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis-a double- blind randomized phase 2 clinical trial. J. Ocul. Pharmacol. Ther. 21: 157-165.
22. Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ. 2006. N-Chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest. Ophthalmol. Vis. Sci. 47:2021-2026.
23. Iovino SM, Krantz KD, Blanco DM, Fernandez JA, Ocampo NF, Najafi A, Memarzadeh B, Celeri CE, Debabov D, Khosrovi B, Anderson M. 2011. NVC-422 topical gel for the treatment of impetigo. Int. J. Clin. Exp. Pathol. 4:587-595.
24. Shiau TP, Houchin A, Nair S, Xu P, Low E, Najafi RR, Jain R. 2009. Stieglitz rearrangement of N, N-dichloro-beta, beta-disubstituted taurines under mild aqueous conditions. Bioorg. Med. Chem. Lett. 19:1110 -1114.
25. Wang L, Belisle B, Bassiri M, Xu P, Debabov D, Celeri C, Alvarez N, Robson MC, Payne WG, Najafi R, Khosrovi B. 2011. Chemical characterization and biological properties of NVC-422, a novel, stable Nchlorotaurine analog. Antimicrob. Agents Chemother. 55:2688 -2692.
26. Wang L, Khosrovi B, Najafi R. 2008. N-Chloro-2, 2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines. Tetrahedron Lett. 49: 2193-2195.
27. Gottardi W, Nagl M. 2005. Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J. Antimicrob. Chemother. 55:475- 482.
28. Marcinkiewicz J, Czajkowska B, Grabowska A, Kasprowicz A, Kociszewska B. 1994. Differential effects of chlorination of bacteria on their capacity to generate NO, TNF-alpha and IL-6 in macrophages. Immunology. 83:611- 616.
29. Arnitz R, Sarg B, Ott HW, Neher A, Lindner H, Nagl M. 2006. Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 6:865-869.
30. Nagl M, Hess M, Pfaller K, Hengster P, Gottardi W. 2000. Bactericidal activity of micromolar N-chlorotaurine-evidence for its antimicrobial function in the human defence system. Antimicrob. Agents Chemother. 44:2507- 2513.
31. Peskin AV, Winterbourn CC. 2006. Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase. Free Radic. Biol. Med. 40:45-53.
32. Gottardi W, Arnitz R, Nagl M. 2007. N-Chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int. J. Pharm. 335:32- 40.
33. Gottardi W, Nagl M. 2002. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch. Pharm. (Weinheim) 335:411- 421.
34. Grisham MB, Jefferson MM, Melton DF, Thomas EL. 1984. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259: 10404-10413.
35. Peskin AV, Winterbourn CC. 2001. Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Radic. Biol. Med. 30:572-579.
36. Peskin AV, Midwinter RG, Harwood DT, Winterbourn CC. 2004. Chlorine transfer between glycine, taurine, and histamine: reaction rates and impact on cellular reactivity. Free Radic. Biol. Med. 37:1622-1630.
37. Thomas EL, Grisham MB, Jefferson MM. 1986. Preparation and characterization of chloramines. Methods Enzymol. 132:569 -585.
38. Stelmaszyńska T, Zgliczynski JM. 1974. Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur. J. Biochem. 45:305-312.
39. Zgliczyński JM, Stelmaszynska T, Domanski J, Ostrowski W. 1971. Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase. Biochim. Biophys. Acta 235:419-424.
40. Gottardi W, Karl A. 1991. Chlorine covers on skin surfaces. II. Parameters influencing the cover strength. Zentralbl. Hyg. Umweltmed. 191:478- 493. (In German.).
41. Gottardi W, Bock V. 1988. The reaction of chloramine T (CAT) with protein constituents: model experiments on the halogen demand during the disinfection of biological material, p 35-60. In Proceedings of the 4th conference on Progress in Chemical Disinfection, Binghamton University, Binghamton, NY.
42. Gottardi W. 1992. Aqueous chloramine T solutions as disinfectants: chemical composition, reactivity and toxicity. Arch. Pharm. (Weinheim) 325:377-384. (In German.).
43. Nagl M, Gottardi W. 1992. In vitro experiments on the bactericidal action of N-chlorotaurine. Hyg. Med. 17:431- 439.
44. Ward NR, Wolfe RL, Olson BH. 1984. Effect of pH, application technique, and chlorine-to-nitrogen ratio on disinfectant activity of inorganic chloramines with pure culture bacteria. Appl. Environ. Microbiol. 48: 508-514.
45. Gottardi W, Nagl M. 2013. Active halogen compounds and proteinaceous material: loss of activity of topical antiinfectives by halogen consumption. J. Pharm. Pharmacol. 65:213-218. doi:10.1111/j.2042-7158, 2012.01589.x.
46. Weiss SJ, Klein R, Slivka A, Wei M. 1982. Chlorination of taurine by human neutrophils. J. Clin. Invest. 70:598-607.
47. Widmer AF, Rotter M, Voss A, Nthumba P, Allegranzi B, Boyce J, Pittet D. 2010. Surgical hand preparation: state-of-the-art. J. Hosp. Infect. 74: 112-122.
48. Weiss SJ, Lampert MB, Test ST. 1983. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 222:625- 628.
49. Gottardi W, Nagl M. 2010. N-Chlorotaurine, a natural antiseptic with outstanding tolerability. J. Antimicrob. Chemother. 65:399-409.
50. Yoon J, Jekle A, Najafi R, Ruado F, Zuck M, Khosrovi B, Memarzadeh B, Debabov D, Wang L, Anderson M. 2011. Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis. Antiviral Res. 92:470-478.
51. Martini C, Hammerer-Lercher A, Zuck M, Jekle A, Debabov D, Anderson M, Nagl M. 2012. Antimicrobial and anticoagulant activity of N-chlorotaurine (NCT), N, N-dichloro-2, 2-dimethyltaurine (NVC-422) and N-monochloro-2, 2-dimethyltaurine (NVC-612) in human blood. Antimicrob. Agents Chemother. 56:1979 -1984.
52. Teuchner B, Eitzinger C, Lutz M, Hager T, Schmid E, Bechrakis NE, Zuck M, Jekle A, Debabov D, Anderson M, Nagl M. 2012. NChlorotaurine and its analogs N, N-dichloro-2, 2-dimethyltaurine and N-monochloro-2, 2-dimethyltaurine are safe and effective bactericidal agents in corneal infection models. Acta Ophthalmol. 90:e632- e637. doi: 10.1111/j.1755-3768.2012.02501.x.
53. D'Lima L, Friedman L, Wang L, Xu P, Anderson M, Debabov D. 2012. No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli. Antimicrob. Agents Chemother. 56: 2753-2755.
54. Darouiche D, Najafi R, Krantz K, Debabov D, Friedman L, Khosrovi B, Wang L, Iovino SM, Anderson M. 2011. NVC-422. Antiinfective agent, treatment of impetigo, treatment of conjunctivitis, treatment of urinary tract infections. Drugs Future 36:651- 656.
55. Nagl M, Hengster P, Semenitz E, Gottardi W. 1999. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J. Antimicrob. Chemother. 43:805- 809.
56. Nagl M, Gruber A, Fuchs A, Lell C, Lemberger EM, Borg-von Zepelin M, Würzner R. 2002. Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob. Agents Chemother. 46:1996 -1999.
57. Reeves EP, Nagl M, O'Keeffe J, Kelly J, Kavanagh K. 2006. Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin. J. Med. Microbiol. 55:913-918.
58. Eitzinger C, Ehrlenbach S, Lindner H, Kremser L, Gottardi W, Debabov D, Anderson M, Nagl M, Orth D. 2012. N-Chlorotaurine, a long-lived oxidant produced by human leukocytes, inactivates Shiga toxin of enterohemorrhagic Escherichia coli. PLoS One 7:e47105.
59. Singhal D, Jekle A, Debabov D, Wang L, Khosrovi B, Anderson M, Foreman A, Wormald PJ. 2012. Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis. Int. Forum Allergy Rhinol. 2:309 -315.
60. Dakin HD. 1916. The behaviour of hypochlorites on intravenous injection and their action on blood serum. Br. Med. J. 1:852- 854.
61. Stief TW, Kurz J, Doss MO, Fareed J. 2000. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood. Thromb. Res. 97:473- 480.
62. Koprowski M, Marcinkiewicz J. 2002. Taurine chloramine-its role in immunity and new perspectives for clinical use. Cent. Eur. J. Immunol. 27:69 -74.
63. Marcinkiewicz J. 1997. Neutrophil chloramines: missing links between innate and acquired immunity. Immunol. Today 18:577-580.
64. Marcinkiewicz J, Kontny E. 19 July 2012. Taurine and inflammatory diseases. Amino Acids [Epub ahead of print.] doi:10.1007/s00726-012 -1361-4.
65. Klamt F, Shacter E. 2005. Taurine chloramine, an oxidant derived from neutrophils, induces apoptosis in human B lymphoma cells through mitochondrial damage. J. Biol. Chem. 280:21346 -21352.
66. Vogt W. 1996. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 195:334 -346.
67. Marcinkiewicz J, Chain B, Nowak B, Grabowska A, Bryniarski K, Baran J. 2000. Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm. Res. 49:280 -289.
68. Neher A, Arnitz R, Gstöttner M, Schäfer D, Kröss E, Nagl M. 2008. Antimicrobial activity of dexamethasone and its combination with Nchlorotaurine. Arch. Otolaryngol. Head Neck Surg. 134:615- 620.
69. Nagl M, Gottardi W. 1996. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg. Med. 21:597- 605.